The Journal of Experimental Medicine
AbD Serotec: www.ab-direct.com/4for3
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online December 11, 2006
doi:10.1084/jem.20061151
The Journal of Experimental Medicine, Vol. 203, No. 13, 2953-2961
The Rockefeller University Press, 0022-1007 $30.00
© 2006 Liu et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, X.
Right arrow Articles by Marrack, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, X.
Right arrow Articles by Marrack, P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

ARTICLE

Bcl-xl does not have to bind Bax to protect T cells from death

Xinqi Liu1,2, Yanan Zhu3, Shaodong Dai1,2, Janice White1,2, Fred Peyerl1,2, John W. Kappler1,2,4, and Philippa Marrack1,2,3

1 Howard Hughes Medical Institute and 2 Integrated Department of Immunology, National Jewish Medical and Research Center, Denver, CO 80206
3 Department of Biochemistry and Molecular Genetics and 4 Program in Biomolecular Structure, Department of Pharmacology, University of Colorado Health Science Center, Denver, CO 80262

CORRESPONDENCE Philippa Marrack: marrackp{at}njc.org OR John W. Kappler kapplerj{at}njc.org

Activated T cells die when antigen disappears from animals. This death is caused by proteins related to Bcl-2. Two hypotheses have been suggested to explain the actions of the different types of Bcl-2 proteins. One hypothesis suggests that, when T cells prepare to die, Bak and Bax, the proteins that actually kill activated T cells, are released from antiapoptotic proteins such as Bcl-2 and Bcl-xl. Another hypothesis suggests that Bak and Bax are normally free and are triggered to kill cells by release of messenger proteins, such as Bim, from Bcl-2 and Bcl-xl. Here, a form of Bcl-xl, which lacks a long unstructured loop, is used to show that the first hypothesis is not correct. Bcl-xl without its loop protects activated T cells from death, yet Bcl-xl without its loop cannot bind any form of Bak and Bax. Thus, binding of Bcl-xl to Bak or Bax is not involved in T cell life or death. The loop of Bcl-xl is also somewhat involved in Bcl-xl's binding of Bim because Bcl-xl without its loop binds Bim less well than wild-type Bcl-xl. Moreover, the loop may have additional, as yet unknown, functions because it changes its shape when Bcl-xl binds Bim.


Abbreviations used: BH3, Bcl-2 homology 3; SEB, staphylococcal enterotoxin B.

X. Liu's present address is Dept. of Biological Science, Purdue University, West Lafayette, IN 47907.

Y. Zhu's present address is Dept. of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94143.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS